I kliniske undersøgelser af behandling af non- nosocomiel pneumoni, hos voksne, havde 25% af de evaluerbare patienter behandlet med ertapenem svær sygdom (defineret som pneumoni sværhedsindex - > III).
In clinical studies for the treatment of community-acquired pneumonia, in adults, 25% of evaluable patients treated with ertapenem had severe disease (defined as pneumonia severity index > III).